Growth Metrics

Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2016 - 2026)

Zimmer Biomet Holdings has reported Cash from Financing Activities over the past 18 years, most recently at -$369.2 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 164.16% year-over-year to -$369.2 million; the TTM value through Mar 2026 reached -$618.6 million, down 538.72%, while the annual FY2025 figure was $326.0 million, 167.29% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$369.2 million at Zimmer Biomet Holdings, up from -$897.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $575.4 million in Q1 2025 and troughed at -$897.0 million in Q4 2025.
  • A 5-year average of -$121.6 million and a median of -$146.0 million in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 415.9% in 2022 and later soared 1248.5% in 2025.
  • Year by year, Cash from Financing Activities stood at -$313.4 million in 2022, then grew by 19.78% to -$251.4 million in 2023, then grew by 4.3% to -$240.6 million in 2024, then crashed by 272.82% to -$897.0 million in 2025, then surged by 58.84% to -$369.2 million in 2026.
  • Business Quant data shows Cash from Financing Activities for ZBH at -$369.2 million in Q1 2026, -$897.0 million in Q4 2025, and $483.8 million in Q3 2025.